NEYPPC-High Tech Homecare Medicines Service(2025)

The Leeds Teaching Hospitals NHS Trust, acting on behalf of the North East & Yorkshire NHS Pharmaceutical Purchasing Consortium (NEYPPC), is establishing a multi-award Framework Agreement for High Tech Homecare Medicines Services. This procurement covers both goods and services for member Trusts within the NEY region, with potential access for other approved publicly funded entities. The framework is divided into six specialized lots: Lot HT26-A for Unlicensed Compounded Desferrioxamine, Lot HT26-B for Unlicensed Compounded Antimicrobials, Lot HT26-C for Unlicensed Compounded Chemotherapy and Monoclonal Antibodies, Lot HT26-D for other Unlicensed Compounded services, Lot HT26-E for Metabolic Disorders, and Lot HT26-F for other Non-compounded High Tech services. The total estimated value of the framework is 200 million GBP excluding VAT, with the highest value assigned to Lot HT26-C at 72 million GBP. The initial period of performance is set from 1 April 2027 to 31 March 2029, with a possible 24-month extension to 31 March 2031. Award decisions will be based on a weighted evaluation consisting of Technical and Quality (50%), Commercial Price (40%), and Social Value (10%). The solicitation is open to various providers, including small and medium-sized enterprises and voluntary, community, and social enterprises.